-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $11 Price Target

Benzinga·04/25/2025 11:03:57
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $11 price target.